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preliminary study, the seated saline infusion test (SSIT) 
was more sensitive than the recumbent saline infusion 
test (RSIT) for the diagnosis and subtype classification of 
PA. However, it is unclear whether the SSIT is suitable for 
Chinese PA patients.
Objective:
We prospectively investigated the accuracy of the seated 
saline infusion test (SSIT) in 113 patients with hyper-
tension (including 93 PA and 20 essential hypertension 
(EH) patients) in the Department of Endocrinology and 
Metabolism.
Approach and Results:
Each patient underwent an recumbent saline infusion test 
(RSIT) and seated saline infusion test (SSIT). The accuracy 
of the SSIT for a confirmative primary aldosteronism (PA) 
diagnosis and subtype classification was evaluated and 
compared with the RSIT. The area under the receiver oper-
ating characteristic (ROC) curve (AUC) of aldosterone for 
the SSIT was significantly greater than that for the RSIT 
(0.945±0.0199 vs 0.828±0.0404; P<0.05). The ROC analysis 
showed that the optimal plasma aldosterone cutoff values 
were 12.94  ng/dl for the SSIT (sensitivity 86.02%, spec-
ificity 95%; Youden index (YI)=0.810) and 12.04  ng/dl for 
the RSIT (sensitivity 83.15%, specificity 57%; Youden index 
(YI)=0.401). The optimal aldosterone concentration cutoff 
value for classifying aldosterone-producing adenoma (APA) 
and idiopathic hyperaldosteronism (IHA) was 18.12  ng/
dl for the SSIT (sensitivity 73.5%, specificity 79.5%). No 
patients experienced adverse events during the SSIT.
Conclusions:
The SSIT was safe and convenient for PA diagnosis. The 
accuracy of the SSIT for a confirmatory diagnosis of PA was 
better than that of the RSIT. The SSIT is a reliable alterna-
tive for PA confirmation in Chinese individuals.
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Background: Adult growth hormone deficiency (AGHD) 
is a debilitating clinical condition leading to decreased 
quality of life (QoL). The impact of reduced muscle mass, 
weakening and loss of vitality on QoL have been well 
characterized in AGHD. The impact of AGHD on sexual 
function, a recognized factor able to modify well-being, has 
never been investigated. Aim: To investigate the prevalence 
of sexual dysfunction in AGHD patients referring to a single 
endocrinological center and grouped according to their his-
tory of r-hGH therapy.Methods: The Management of Adult 
Growth Hormone Deficiency (MAGHD) Study is a pro-
spective, real-life trial aiming to improve management of 
AGHD patients through a smartphone app (MAGHD App) 
and a wearable device. The 83 AGHD enrolled patients (31 
Females, 52 Males, mean age 56.27  +  14.68  years) were 
divided in 3 groups (G) according to r-hGH therapy: on 
long-term r-hGH therapy (G1, n=32), previously treated 
with r-hGH (G2, n=20), never treated (G3, n=31). Within 
the first phase of the study, a large database was created 
collecting clinical, biochemical and psychological data. In 
addition to QLS-H and QoL-AGHDA routinely used to as-
sess QoL, IIEF-15 and FSFI were employed to evaluate 
sexual function in males and females, respectively. The 
nonparametric Kruskal-Wallis test was used for compar-
ison among 3 groups.Results: Here only baseline data of the 
MAGHD Study are presented.According to IIEF-15 results, 
the prevalence of erectile dysfunction (ED) in male AGHD 
cohort was 60%. Erectile function (EF) score was signifi-
cantly higher in G1 compared to both G2 and G3 (p < 0.05) 
with an ED prevalence of 35% in G1, 75% in G2 and 75% in 
G3. Even excluding patients with serum testosterone lower 
than 2 ng/ml and older than 65 years, ED prevalence did 
not change significantly in the 3 groups. Moreover, EF do-
main was inversely and directly correlated to age (R20.130, 
β-0.360) and IGF1 levels (R20.156, β0.395), respectively. 
The prevalence of female sexual dysfunction according to 
FSFI was 89.3%. Even though desire, arousal, lubrication 
and overall scores were significantly higher (better results) 
in G1 compared to G2 and G3 (p < 0.05), no correlation 
resulted between FSFI domains and IGF1 levels. Instead 
an inverse correlation resulted between desire domain and 
age.Conclusions: This study, performed in a real-life clinical 
setting, demonstrates a high prevalence of sexual dysfunc-
tion in AGHD patients and that r-hGH treatment seems 
to be associated to better sexual outcomes. These results 
suggest that the evaluation of sexual function should be in-
tegrated in the global assessment of AGHD patients since 
sexual activity is a fundamental domain able to influence 
both well-being and QoL.
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In female animals, ovarian estradiol (E2) can act as both 
a negative feedback inhibitor of GnRH secretion, as well 
as a positive feedback stimulator at the time of ovulation. 
Both of these E2-regulated mechanisms work via stimu-
lation or repression of two distinct neuronal populations 
of Kisspeptin (KP)-synthesizing neurons. While it is clear 
that AVPV KP neurons increase kiss1 expression during 
the preovulatory surge on proestrus, subsequent secretory 
mechanisms required for potentiation of GnRH surge re-
lease remain unclear. Two KP-secreting cell lines, KTaV-3, 
which demonstrate increased kiss1 expression under high 
E2 exposure, and KTaR-1, which exhibit kiss1 suppression 
under low E2 exposure, were used to probe the presence of 
GnRH receptor (GnRHR) expression under different E2 ex-
posure conditions.
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